Alpha Paradigm Partners, LLC Novavax Inc Transaction History

Alpha Paradigm Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $50,902 - $104,317	730 Added 10428.57%	737 $54 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $107,746 - $163,971	-606 Reduced 98.86%	7 $1 Million
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $396,275 - $843,869	-3,275 Reduced 84.23%	613 $130 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $306,141 - $542,376	3,888 New	3,888 $434,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.